MANE
Veradermics, Incorporated
NYSE: MANE · HEALTHCARE · BIOTECHNOLOGY
$99.00
-7.09% today
Updated 2026-04-30
Market cap
$3.74B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.37
Dividend yield
—
52W range
$32 – $110
Volume
0.5M
Veradermics, Incorporated (MANE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 1
Last 1 quarters
Avg EPS surprise
+95.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.6%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-3.6%
2026-03-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-30 | $-0.76 | +95.9% | $65.53 | $63.15 | -3.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-18.24 | $-0.76 | +95.9% | — | — |
Frequently asked questions
Has Veradermics, Incorporated beaten earnings estimates?
Veradermics, Incorporated has beaten Wall Street EPS estimates in 1 of its last 1 quarterly reports, with an average EPS surprise of +95.9% over the last 1 quarters.
How does MANE stock react to earnings?
MANE stock has moved an average of -3.6% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.